aluates Reports

$ 0.0

Automative

Global Acute Kidney Injury Therapeutics Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-9L14504

Global Acute Kidney Injury Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Acute Kidney Injury Therapeutics Market Research Report 2024

Q: Who are the main players in the Acute Kidney Injury Therapeutics Market report?

The main players in the Acute Kidney Injury Therapeutics Market are Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux, A1M Pharma

Q: What are the Application segmentation covered in the Acute Kidney Injury Therapeutics Market report?

The Applications covered in the Acute Kidney Injury Therapeutics Market report are Hospitals, Clinic, Other

Q: What are the Type segmentation covered in the Acute Kidney Injury Therapeutics Market report?

The Types covered in the Acute Kidney Injury Therapeutics Market report are Non-drug, Drugs

Code: QYRE-Auto-9L14504

Report

April 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Quark Pharmaceuticals

Alloksys

Angio Biomedica Corporation

Stealth Bio Therapeutics

Silver Creek Pharmaceuticals

Acute Kidney Injury Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Acute Kidney Injury Therapeutics Market

Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h).

The global Acute Kidney Injury Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Therapeutics.

Report Scope

The Acute Kidney Injury Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Kidney Injury Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Kidney Injury Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acute Kidney Injury Therapeutics Market Report

Report Metric	Details
Report Name	Acute Kidney Injury Therapeutics Market
CAGR	5%
Segment by Type	Non-drug Drugs
Segment by Application	Hospitals Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux, A1M Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Kidney Injury Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acute Kidney Injury Therapeutics Market report?

Ans: The main players in the Acute Kidney Injury Therapeutics Market are Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux, A1M Pharma

What are the Application segmentation covered in the Acute Kidney Injury Therapeutics Market report?

Ans: The Applications covered in the Acute Kidney Injury Therapeutics Market report are Hospitals, Clinic, Other

What are the Type segmentation covered in the Acute Kidney Injury Therapeutics Market report?

Ans: The Types covered in the Acute Kidney Injury Therapeutics Market report are Non-drug, Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Non-drug

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global Acute Kidney Injury Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acute Kidney Injury Therapeutics Market Perspective (2019-2030)

2.2 Acute Kidney Injury Therapeutics Growth Trends by Region

2.2.1 Global Acute Kidney Injury Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Acute Kidney Injury Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Acute Kidney Injury Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Acute Kidney Injury Therapeutics Market Dynamics

2.3.1 Acute Kidney Injury Therapeutics Industry Trends

2.3.2 Acute Kidney Injury Therapeutics Market Drivers

2.3.3 Acute Kidney Injury Therapeutics Market Challenges

2.3.4 Acute Kidney Injury Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue

3.1.1 Global Top Acute Kidney Injury Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Acute Kidney Injury Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Acute Kidney Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Acute Kidney Injury Therapeutics Revenue

3.4 Global Acute Kidney Injury Therapeutics Market Concentration Ratio

3.4.1 Global Acute Kidney Injury Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Therapeutics Revenue in 2023

3.5 Acute Kidney Injury Therapeutics Key Players Head office and Area Served

3.6 Key Players Acute Kidney Injury Therapeutics Product Solution and Service

3.7 Date of Enter into Acute Kidney Injury Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Kidney Injury Therapeutics Breakdown Data by Type

4.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2025-2030)

5 Acute Kidney Injury Therapeutics Breakdown Data by Application

5.1 Global Acute Kidney Injury Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Acute Kidney Injury Therapeutics Market Size (2019-2030)

6.2 North America Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Acute Kidney Injury Therapeutics Market Size by Country (2019-2024)

6.4 North America Acute Kidney Injury Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Acute Kidney Injury Therapeutics Market Size (2019-2030)

7.2 Europe Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Acute Kidney Injury Therapeutics Market Size by Country (2019-2024)

7.4 Europe Acute Kidney Injury Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Acute Kidney Injury Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Acute Kidney Injury Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Acute Kidney Injury Therapeutics Market Size (2019-2030)

9.2 Latin America Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Acute Kidney Injury Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Acute Kidney Injury Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Acute Kidney Injury Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Quark Pharmaceuticals

11.1.1 Quark Pharmaceuticals Company Detail

11.1.2 Quark Pharmaceuticals Business Overview

11.1.3 Quark Pharmaceuticals Acute Kidney Injury Therapeutics Introduction

11.1.4 Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.1.5 Quark Pharmaceuticals Recent Development

11.2 Alloksys

11.2.1 Alloksys Company Detail

11.2.2 Alloksys Business Overview

11.2.3 Alloksys Acute Kidney Injury Therapeutics Introduction

11.2.4 Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.2.5 Alloksys Recent Development

11.3 Angio Biomedica Corporation

11.3.1 Angio Biomedica Corporation Company Detail

11.3.2 Angio Biomedica Corporation Business Overview

11.3.3 Angio Biomedica Corporation Acute Kidney Injury Therapeutics Introduction

11.3.4 Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.3.5 Angio Biomedica Corporation Recent Development

11.4 Stealth Bio Therapeutics

11.4.1 Stealth Bio Therapeutics Company Detail

11.4.2 Stealth Bio Therapeutics Business Overview

11.4.3 Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Introduction

11.4.4 Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.4.5 Stealth Bio Therapeutics Recent Development

11.5 Silver Creek Pharmaceuticals

11.5.1 Silver Creek Pharmaceuticals Company Detail

11.5.2 Silver Creek Pharmaceuticals Business Overview

11.5.3 Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Introduction

11.5.4 Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.5.5 Silver Creek Pharmaceuticals Recent Development

11.6 AM Pharma Holding

11.6.1 AM Pharma Holding Company Detail

11.6.2 AM Pharma Holding Business Overview

11.6.3 AM Pharma Holding Acute Kidney Injury Therapeutics Introduction

11.6.4 AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.6.5 AM Pharma Holding Recent Development

11.7 Ischemix

11.7.1 Ischemix Company Detail

11.7.2 Ischemix Business Overview

11.7.3 Ischemix Acute Kidney Injury Therapeutics Introduction

11.7.4 Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.7.5 Ischemix Recent Development

11.8 Biomerieux

11.8.1 Biomerieux Company Detail

11.8.2 Biomerieux Business Overview

11.8.3 Biomerieux Acute Kidney Injury Therapeutics Introduction

11.8.4 Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.8.5 Biomerieux Recent Development

11.9 A1M Pharma

11.9.1 A1M Pharma Company Detail

11.9.2 A1M Pharma Business Overview

11.9.3 A1M Pharma Acute Kidney Injury Therapeutics Introduction

11.9.4 A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2019-2024)

11.9.5 A1M Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Quark Pharmaceuticals

Alloksys

Angio Biomedica Corporation

Stealth Bio Therapeutics

Silver Creek Pharmaceuticals

List of Tables

Table 1. Global Acute Kidney Injury Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Non-drug

Table 3. Key Players of Drugs

Table 4. Global Acute Kidney Injury Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Acute Kidney Injury Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Acute Kidney Injury Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Acute Kidney Injury Therapeutics Market Share by Region (2019-2024)

Table 8. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Acute Kidney Injury Therapeutics Market Share by Region (2025-2030)

Table 10. Acute Kidney Injury Therapeutics Market Trends

Table 11. Acute Kidney Injury Therapeutics Market Drivers

Table 12. Acute Kidney Injury Therapeutics Market Challenges

Table 13. Acute Kidney Injury Therapeutics Market Restraints

Table 14. Global Acute Kidney Injury Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Acute Kidney Injury Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Therapeutics as of 2023)

Table 17. Ranking of Global Top Acute Kidney Injury Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Acute Kidney Injury Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Acute Kidney Injury Therapeutics Product Solution and Service

Table 21. Date of Enter into Acute Kidney Injury Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Acute Kidney Injury Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Acute Kidney Injury Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Acute Kidney Injury Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Acute Kidney Injury Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Acute Kidney Injury Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Acute Kidney Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Acute Kidney Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Acute Kidney Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Acute Kidney Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Acute Kidney Injury Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Acute Kidney Injury Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Acute Kidney Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Acute Kidney Injury Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Acute Kidney Injury Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Quark Pharmaceuticals Company Detail

Table 47. Quark Pharmaceuticals Business Overview

Table 48. Quark Pharmaceuticals Acute Kidney Injury Therapeutics Product

Table 49. Quark Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 50. Quark Pharmaceuticals Recent Development

Table 51. Alloksys Company Detail

Table 52. Alloksys Business Overview

Table 53. Alloksys Acute Kidney Injury Therapeutics Product

Table 54. Alloksys Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Alloksys Recent Development

Table 56. Angio Biomedica Corporation Company Detail

Table 57. Angio Biomedica Corporation Business Overview

Table 58. Angio Biomedica Corporation Acute Kidney Injury Therapeutics Product

Table 59. Angio Biomedica Corporation Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Angio Biomedica Corporation Recent Development

Table 61. Stealth Bio Therapeutics Company Detail

Table 62. Stealth Bio Therapeutics Business Overview

Table 63. Stealth Bio Therapeutics Acute Kidney Injury Therapeutics Product

Table 64. Stealth Bio Therapeutics Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Stealth Bio Therapeutics Recent Development

Table 66. Silver Creek Pharmaceuticals Company Detail

Table 67. Silver Creek Pharmaceuticals Business Overview

Table 68. Silver Creek Pharmaceuticals Acute Kidney Injury Therapeutics Product

Table 69. Silver Creek Pharmaceuticals Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Silver Creek Pharmaceuticals Recent Development

Table 71. AM Pharma Holding Company Detail

Table 72. AM Pharma Holding Business Overview

Table 73. AM Pharma Holding Acute Kidney Injury Therapeutics Product

Table 74. AM Pharma Holding Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 75. AM Pharma Holding Recent Development

Table 76. Ischemix Company Detail

Table 77. Ischemix Business Overview

Table 78. Ischemix Acute Kidney Injury Therapeutics Product

Table 79. Ischemix Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Ischemix Recent Development

Table 81. Biomerieux Company Detail

Table 82. Biomerieux Business Overview

Table 83. Biomerieux Acute Kidney Injury Therapeutics Product

Table 84. Biomerieux Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Biomerieux Recent Development

Table 86. A1M Pharma Company Detail

Table 87. A1M Pharma Business Overview

Table 88. A1M Pharma Acute Kidney Injury Therapeutics Product

Table 89. A1M Pharma Revenue in Acute Kidney Injury Therapeutics Business (2019-2024) & (US$ Million)

Table 90. A1M Pharma Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acute Kidney Injury Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Acute Kidney Injury Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Non-drug Features

Figure 4. Drugs Features

Figure 5. Global Acute Kidney Injury Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Acute Kidney Injury Therapeutics Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Acute Kidney Injury Therapeutics Report Years Considered

Figure 11. Global Acute Kidney Injury Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Acute Kidney Injury Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Acute Kidney Injury Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global Acute Kidney Injury Therapeutics Market Share by Players in 2023

Figure 15. Global Top Acute Kidney Injury Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Kidney Injury Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Acute Kidney Injury Therapeutics Revenue in 2023

Figure 17. North America Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Acute Kidney Injury Therapeutics Market Share by Country (2019-2030)

Figure 19. United States Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Acute Kidney Injury Therapeutics Market Share by Country (2019-2030)

Figure 23. Germany Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Acute Kidney Injury Therapeutics Market Share by Region (2019-2030)

Figure 31. China Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Acute Kidney Injury Therapeutics Market Share by Country (2019-2030)

Figure 39. Mexico Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Acute Kidney Injury Therapeutics Market Share by Country (2019-2030)

Figure 43. Turkey Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Acute Kidney Injury Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Quark Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 46. Alloksys Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 47. Angio Biomedica Corporation Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 48. Stealth Bio Therapeutics Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 49. Silver Creek Pharmaceuticals Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 50. AM Pharma Holding Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 51. Ischemix Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 52. Biomerieux Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 53. A1M Pharma Revenue Growth Rate in Acute Kidney Injury Therapeutics Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Laser Blood Irradiation Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3T15192

Thu May 16 00:00:00 UTC 2024

Add to Cart

Global Manual Nasal Irrigators Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17K12459

Thu May 16 00:00:00 UTC 2024

Add to Cart

Global Blood Vessels Embolic Agents Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12S15108

Thu May 16 00:00:00 UTC 2024

Add to Cart

Global Interventional Lung Solutions Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-27K12228

Thu May 16 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions